Copyright Reports & Markets. All rights reserved.

Global Meningococcal Infections Vaccine Market Growth (Status and Outlook) 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Meningococcal Infections Vaccine Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Meningococcal Infections Vaccine Market Size 2014-2024
        • 2.1.2 Meningococcal Infections Vaccine Market Size CAGR by Region
      • 2.2 Meningococcal Infections Vaccine Segment by Type
        • 2.2.1 Quadrivalent (Serogroups A, C, W-135, and Y)
        • 2.2.2 Bivalent (Serogroups C and Y)
        • 2.2.3 Serogroup A
        • 2.2.4 Serogroup B
        • 2.2.5 Serogroup X
      • 2.3 Meningococcal Infections Vaccine Market Size by Type
        • 2.3.1 Global Meningococcal Infections Vaccine Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Meningococcal Infections Vaccine Market Size Growth Rate by Type (2014-2019)
      • 2.4 Meningococcal Infections Vaccine Segment by Application
        • 2.4.1 Hospital
        • 2.4.2 Clinic
      • 2.5 Meningococcal Infections Vaccine Market Size by Application
        • 2.5.1 Global Meningococcal Infections Vaccine Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Meningococcal Infections Vaccine Market Size Growth Rate by Application (2014-2019)

      3 Global Meningococcal Infections Vaccine by Players

      • 3.1 Global Meningococcal Infections Vaccine Market Size Market Share by Players
        • 3.1.1 Global Meningococcal Infections Vaccine Market Size by Players (2017-2019)
        • 3.1.2 Global Meningococcal Infections Vaccine Market Size Market Share by Players (2017-2019)
      • 3.2 Global Meningococcal Infections Vaccine Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Meningococcal Infections Vaccine by Regions

      • 4.1 Meningococcal Infections Vaccine Market Size by Regions
      • 4.2 Americas Meningococcal Infections Vaccine Market Size Growth
      • 4.3 APAC Meningococcal Infections Vaccine Market Size Growth
      • 4.4 Europe Meningococcal Infections Vaccine Market Size Growth
      • 4.5 Middle East & Africa Meningococcal Infections Vaccine Market Size Growth

      5 Americas

      • 5.1 Americas Meningococcal Infections Vaccine Market Size by Countries
      • 5.2 Americas Meningococcal Infections Vaccine Market Size by Type
      • 5.3 Americas Meningococcal Infections Vaccine Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Meningococcal Infections Vaccine Market Size by Countries
      • 6.2 APAC Meningococcal Infections Vaccine Market Size by Type
      • 6.3 APAC Meningococcal Infections Vaccine Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Meningococcal Infections Vaccine by Countries
      • 7.2 Europe Meningococcal Infections Vaccine Market Size by Type
      • 7.3 Europe Meningococcal Infections Vaccine Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Meningococcal Infections Vaccine by Countries
      • 8.2 Middle East & Africa Meningococcal Infections Vaccine Market Size by Type
      • 8.3 Middle East & Africa Meningococcal Infections Vaccine Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Meningococcal Infections Vaccine Market Forecast

      • 10.1 Global Meningococcal Infections Vaccine Market Size Forecast (2019-2024)
      • 10.2 Global Meningococcal Infections Vaccine Forecast by Regions
        • 10.2.1 Global Meningococcal Infections Vaccine Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Meningococcal Infections Vaccine Forecast by Type
      • 10.8 Global Meningococcal Infections Vaccine Forecast by Application

      11 Key Players Analysis

      • 11.1 Creative Biolabs(USA)
        • 11.1.1 Company Details
        • 11.1.2 Meningococcal Infections Vaccine Product Offered
        • 11.1.3 Creative Biolabs(USA) Meningococcal Infections Vaccine Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Creative Biolabs(USA) News
      • 11.2 SERUM INSTITUTE OF INDIA PVT.LTD.(India)
        • 11.2.1 Company Details
        • 11.2.2 Meningococcal Infections Vaccine Product Offered
        • 11.2.3 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Meningococcal Infections Vaccine Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 SERUM INSTITUTE OF INDIA PVT.LTD.(India) News

      ...

        12 Research Findings and Conclusion

        Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitidis.Different versions are effective against some or all of the following types of meningococcus: A, C, W-135,and Y.The vaccines are between 85 and 100% effective for at least two years.They result in a decrease in meningitis and sepsis among populations where they are widely used.They are given either by injection into a muscle or just under the skin.

        According to this study, over the next five years the Meningococcal Infections Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Meningococcal Infections Vaccine business, shared in Chapter 3.

        This report presents a comprehensive overview, market shares and growth opportunities of Meningococcal Infections Vaccine market by product type, application, key companies and key regions.

        This study considers the Meningococcal Infections Vaccine value generated from the sales of the following segments:

        Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
        Quadrivalent (Serogroups A, C, W-135, and Y)
        Bivalent (Serogroups C and Y)
        Serogroup B
        Serogroup X
        Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
        Hospital
        Clinic

        This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
        Americas
        United States
        Canada
        Mexico
        Brazil
        APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

        The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
        Creative Biolabs(USA)
        SERUM INSTITUTE OF INDIA PVT.LTD.(India)
        ...

        In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

        Research objectives
        To study and analyze the global Meningococcal Infections Vaccine market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
        To understand the structure of Meningococcal Infections Vaccine market by identifying its various subsegments.
        Focuses on the key global Meningococcal Infections Vaccine players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
        To analyze the Meningococcal Infections Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
        To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
        To project the size of Meningococcal Infections Vaccine submarkets, with respect to key regions (along with their respective key countries).
        To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
        To strategically profile the key players and comprehensively analyze their growth strategies.

        Buy now